BlueWillow Biologics awarded patent for intranasal genital herpes vaccine
Tuesday, July 23, 2019 DrugName : NanoVax (HSV) vaccine herpes simplex virus 2 vaccine BlueWillow Biologics announced the issuance of U.S.
Read More
Tuesday, July 23, 2019 DrugName : NanoVax (HSV) vaccine herpes simplex virus 2 vaccine BlueWillow Biologics announced the issuance of U.S.
Read MoreThe term of validity of mailbox drug patents in Brazil is limited to twenty years from the filing date of
Read MoreThursday, May 30, 2019 This research work reviews the pros and cons of the existing cell-laden rapid prototyping (RP)
Read MoreMonday, July 22, 2019 Gilead Sciences has secured an antiviral deal with Novartis to gain exclusive global rights to preclinical
Read Moreby Pharmapproc, The US pharmaceutical industry is a highly globalized industry with an enormous positive influence on global health, prosperity and
Read More